Ultiva (Mylan Institutional LLC)
Welcome to the PulseAid listing for the Ultiva drug offered from Mylan Institutional LLC. This Full Opioid Agonists [MoA],Opioid Agonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Mylan Institutional LLC |
NON-PROPRIETARY NAME: | Remifentanil Hydrochloride |
SUBSTANCE NAME: | REMIFENTANIL HYDROCHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Full Opioid Agonists [MoA],Opioid Agonist [EPC] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 1996-11-06 |
END MARKETING DATE: | 0000-00-00 |
Ultiva HUMAN PRESCRIPTION DRUG Details:
Item Description | Ultiva from Mylan Institutional LLC |
LABELER NAME: | Mylan Institutional LLC |
DEA SCHEDULE: | CII
|
ACTIVE STRENGTH: | 1(mg/mL) |
START MARKETING DATE: | 1996-11-06 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 67457-198_6d30fdea-3c76-4be6-9814-372c8f55499b |
PRODUCT NDC: | 67457-198 |
APPLICATION NUMBER: | NDA020630 |
Other REMIFENTANIL HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: